|
FR3093894A1
|
|
NEW USES OF MUTED LACTONASE AND COMPOSITIONS
|
|
FR3082208A1
|
|
METHOD OF MODIFYING A TARGET NUCLEIC ACID SEQUENCE OF A HOST CELL
|
|
EP3642323A1
|
|
Method for preserving a sample of bacteria
|
|
FR3078166A1
|
|
METHOD OF DETERMINING A PATHOLOGY OR SPECIES BY ANALYSIS OF FECAL MATERIAL BY MALDI-TOF TYPE MASS SPECTROMETRY
|
|
FR3075224A1
|
|
METHOD OF DIAGNOSING BACTERIAL VAGINOSIS BY DETECTION OF METHANOBREVIBACTER SMITHII
|
|
FR3070046A1
|
|
MULTIPURPOSE CULTURE MEDIUM FOR ANAEROBIC BACTERIA IN AEROBIA
|
|
FR3069163A1
|
|
AQUEOUS EXTRACT FROM A PLANAR BROYAT
|
|
FR3068987A1
|
|
PROCESS FOR PREPARING A BI-PHASIC BACTERIA CULTURE MEDIUM
|
|
FR3067360A1
|
|
MEDIUM AND METHOD FOR CULTURE AND SELECTIVE ISOLATION OF ENTEROCOCCUS HIRAE BACTERIA
|
|
FR3065226A1
|
|
USE OF URIC ACID FOR CELL CULTURE UNDER THE AEROBIC ATMOSPHERE NOT SUPPLEMENTED WITH CO 2
|
|
FR3061913A1
|
|
MULTI-PURPOSE SELECTIVE CULTURE MEDIUM FOR THE ISOLATION AND SELECTION OF COLISTIN-VANCOMYCIN-RESISTANT BACTERIA
|
|
FR3061912A1
|
|
TRANSPORT AND / OR CULTURE MEDIA FOR MYCOBACTERIUM TUBERCULOSIS
|
|
FR3057463A1
|
|
ASSOCIATION OF ANTIBIOTIC COMPOUNDS EFFECTIVE AGAINST ENTEROBACTERIES
|
|
WO2017055728A2
|
|
Method and system for verifying the presence of an invasive device
|
|
WO2016066930A1
|
|
Method for identifying a microbe in a clinical sample and bank of mass spectra obtained by maldi-tof mass spectrometry
|
|
CN107002115A
|
|
Analyze and explain the automatic mode of antimicrobial sensitivity testses
|
|
FR3035409A1
|
|
DNA EXTRACTION METHOD COMPRISING AN ENZYMATIC DEGRADATION TREATMENT OF A BIOLOGICAL SAMPLE
|
|
FR3033576A1
|
|
METHOD OF INACTIVATING AN INFECTIOUS AGENT IN A BIOLOGICAL SAMPLE
|
|
FR3033575A1
|
|
MEDIUM AND METHOD FOR CULTURING MYCOBACTERIA COMPRISING LAMB SERUM
|
|
FR3028858A1
|
|
BORRELIA CROCIDURAE SPECIFIC MONOCLONAL ANTIBODY AND IN VITRO DIAGNOSTIC METHOD FOR RECURRENT BORRELOSE FEVER
|
